C

Medtronic plc MDT

$92.77 $0.170.18% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Medtronic plc is a global medical technology company focused on the development, manufacturing, and commercialization of medical devices, software, and therapy-based healthcare solutions. The company operates across the broader healthcare and life sciences industries, with core activities spanning cardiovascular care, neuroscience, surgical technologies, diabetes management, and patient monitoring. Its primary revenue drivers include implantable cardiac devices, minimally invasive surgical systems, neurostimulation therapies, insulin delivery technologies, and hospital-based monitoring platforms. Medtronic serves hospitals, physicians, ambulatory surgery centers, healthcare systems, and patients across both developed and emerging healthcare markets.

The company traces its origins to 1949 in Minneapolis, Minnesota, where it began as a medical equipment repair business founded by Earl Bakken and Palmer Hermundslie. Medtronic evolved into a major medical device manufacturer through decades of product innovation and acquisitions, including the transformational acquisition of Covidien in 2015, which significantly expanded its surgical and hospital care portfolio and led to the establishment of Medtronic plc in Ireland. The company’s scale, broad therapy portfolio, clinical data infrastructure, physician relationships, and global distribution network are widely viewed as key competitive advantages within the medical technology sector.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Thursday, September 3, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 23 and 27 (est)

Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)

Corporate Info

Phone Number
353 1 438 1700
Address
Building Two
Parkmore Business Park West
Galway, H91 4K49
Country
Year Founded

Headlines